BYOM JOHN E - 06 Aug 2024 Form 4 Insider Report for Prestige Consumer Healthcare Inc. (PBH)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
07 Aug 2024, 16:03:59 UTC
Prior SEC filing
03 Aug 2023
Next SEC filing
06 Aug 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ John E. Byom by Christine Sacco Attorney-in-Fact pursuant to Power of Attorney dated May 8, 2017 on file with the Commission

Key filing fact

BYOM JOHN E filed Form 4 for Prestige Consumer Healthcare Inc. (PBH) on 07 Aug 2024.

Key facts

  • This page summarizes BYOM JOHN E's Form 4 filing for Prestige Consumer Healthcare Inc. (PBH).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 07 Aug 2024, 16:03.

Change

  • Previous filing in this sequence was filed on 03 Aug 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PBH transaction

Common Stock, par value $0.01 per share

Award

Transaction value
$0
Shares
+2,202
Change %
+4.4%
Price
$0.000000
Shares after
52,500
Date
06 Aug 2024
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Reporting Person received 2,202 restricted stock units equal to $150,000 divided by the closing stock price of $68.13 on August 6, 2024, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .